Omicron Variant & New Therapeutics for COVID-19
This past Feb. 7th, Dr. Chapman presented the clinical characteristics of the Omicron variant and potential for immune escape, and he provided a step wise approach to treating mild to moderate COVID-19 in patients at risk for hospitalization and disease progression. He also advised on how to use Sotrovimab, Paxlovid, and Remdesivir for this indication.
Dr. Michael Chapman Regional Division Head, Infectious Diseases, Surrey Memorial Hospital
Click here to watch the presentation on demand
View the presentation (PDF)
Related Posts
Register Now for Quality Forum 2025
This year’s theme is Embracing Human Connection – exploring the power of relati
Quality Forum 2024
Pre Forum: April 23, 2024 Main Forum takes place April 24-25, 2024 The Quality Forum is the annu
National Indigenous Peoples Day
National Indigenous History Day is a time to acknowledge the rich and diverse cultures, traditio